Patient Management in the Emergency Department during a COVID-19 Pandemic
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Analyzed Groups
3.2. Diagnoses
3.3. Hospitalizations
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), Johns Hopkins University. Available online: https://coronavirus.jhu.edu/map.html (accessed on 8 March 2022).
- Papadimos, T.; Soghoian, S.; Nanayakkara, P.; Singh, S.; Miller, A.C.; Saddikuti, V.; Jayatilleke, A.U.; Dubhashi, S.P.; Firstenberg, M.S.; Dutta, V.; et al. COVID-19 blind spots: A consensus statement on the importance of competent political leadership and the need for public health cognizance. J. Glob. Infect. Dis. 2020, 12, 167–190. [Google Scholar]
- Robakowski, P.; Synoweć, J. Health Policy in the Republic of Poland: What Has Changed During the COVID-19 Pandemic. Studia Polit. 2020, 48, 85–105. [Google Scholar]
- Sukut, O.; Ayhan Balik, C.H. The impact of COVID-19 pandemic on people with severe mental illness. Perspect. Psychiatr. Care 2021, 57, 953–956. [Google Scholar]
- Duan, L.; Zhu, G. Psychological interventions for people affected by the COVID-19 epidemic. Lancet Psychiatry 2020, 7, 300–302. [Google Scholar]
- Microsoft Excel. Available online: https://office.microsoft.com/excel (accessed on 10 May 2022).
- StataCorp. Stata Statistical Software: Release 15; StataCorp LLC: College Station, TX, USA, 2017. [Google Scholar]
- Wang, C.; Horby, P.W.; Hayden, F.G.; Gao, G.F. A novel coronavirus outbreak of global health concern. Lancet 2020, 395, 470–473. [Google Scholar]
- COVID-19 Daily Epidemiology Update. Key Updates as of 11 April 2021. Available online: https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html?redir=1 (accessed on 11 April 2021).
- Halperin, D.T.; Hearst, N.; Hodgins, S.; Bailey, R.C.; Klausner, J.D.; Jackson, H.; Wamai, R.G.; Ladapo, J.A.; Over, M.; Baral, S.; et al. Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here. BMC Public Health 2021, 21, 2084. [Google Scholar]
- Brusselaers, N.; Steadson, D.; Bjorklund, K.; Breland, S.; Stilhoff Sörensen, J.; Ewing, A.; Bergmann, S.; Steineck, G. Evaluation of science advice during the COVID-19 pandemic in Sweden. Humanit. Soc. Sci. Commun. 2022, 9, 91. [Google Scholar]
- Martínez-Salazar, B.; Holwerda, M.; Stüdle, C.; Piragyte, I.; Mercader, N.; Engelhardt, B.; Rieben, R.; Döring, Y. COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences. Front. Cell Dev. Biol. 2022, 1015, 824851. [Google Scholar]
- Al-Awwal, N.; Dweik, F.; Mahdi, S.; El-Dweik, M.; Anderson, S.H. A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time. Pathogens 2022, 11, 368. [Google Scholar]
- Anzola, D.; Limoges, J.; McLean, J.; Kolla, N.J. Effects of the COVID-19 Pandemic on the Mental Health of Healthcare Providers: A Comparison of a Psychiatric Hospital and a General Hospital. Front. Psychiatry 2022, 1214, 720693. [Google Scholar]
- Kavoor, A.R. COVID-19 in people with mental illness: Challenges and vulnerabilities. Asian J. Psychiatr. 2020, 51, 102051. [Google Scholar]
- Zgliczyńska, M.; Kosińska-Kaczyńska, K. Przebieg infekcji SARS-CoV-2 u kobiet ciężarnych—przegląd literatury. Wiedza Med. 2020, 24–30. [Google Scholar]
- Breslin, N.; Baptiste, C.; Gyamfi-Bannerman, C.; Miller, R.; Martinez, R.; Bernstein, K.; Ring, L. COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am. J. Obstet. Gynecol. MFM 2020, 100118. [Google Scholar] [CrossRef]
- Wu, Z.; McGoogan, J.M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020, 323, 1239–1242. [Google Scholar]
- Wang, S.; Mulier, S.; Jonscher, C.; Ye, S.; Chen, L.; Feng, Y.; Li, Y.; Ni, Y. Hypothesis: What is the Best We Can Do with Hydroxychloroquine for COVID-19? Clin. Epidemiol. 2020, 12, 1139–1144. [Google Scholar]
- Onder, G.; Rezza, G.; Brusaferro, S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020, 323, 1775–1776. [Google Scholar] [CrossRef]
- Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020, 395, 1054–1062. [Google Scholar]
- Li, B.; Yang, J.; Zhao, F.; Zhi, L.; Wang, X.; Liu, L.; Bi, Z.; Zhao, Y. Prevalence and impact of cardiovascular metabolic diseases on COVID 19 in China. Clin. Res. Cardiol. 2020, 109, 531–538. [Google Scholar] [CrossRef]
- Cenko, E.; Badimon, L.; Bugiardini, R.; Claeys, M.J.; De Luca, G.; De Wit, C.; Derumeaux, G.; Dorobantu, M.; Duncker, D.J.; Eringa, E.C.; et al. Cardiovascular disease and COVID-19: A consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc. Res. 2021, 117, 2705–2729. [Google Scholar] [CrossRef]
- Shi, S.; Qin, M.; Shen, B.; Cai, Y.; Liu, T.; Yang, F.; Gong, W.; Liu, X.; Liang, J.; Zhao, Q.; et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020, 5, 802–810. [Google Scholar] [CrossRef]
- Xie, Y.; Xu, E.; Bowe, B.; Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022, 28, 583–590. [Google Scholar] [CrossRef]
- Sürme, Y.; Özmen, N.; Ertürk Arik, B. Fear of COVID-19 and Related Factors in Emergency Department Patients. Int. J. Ment. Health Addict. 2021, 1–9. [Google Scholar] [CrossRef]
- Kanownik, G. Hospital management strategy in the aspect of visualization of the pandemic COVID-19. J. Educ. Health Sport 2021, 11, 143–156. [Google Scholar]
Age Group | Number of Patients and % |
---|---|
90+ | 47 (3.75%) |
80–89 | 113 (9.03%) |
70–79 | 208 (16.61%) |
60–69 | 217 (17.33%) |
50–59 | 151 (12.06%) |
40–49 | 117 (9.35%) |
30–39 | 156 (12.465) |
20–29 | 129 (10.3%) |
10–19 | 46 (3.67%) |
1–9 | 68 (5.43%) |
Sex | |
Women | 561 (44.8%) |
Men | 691 (55.2%) |
Average of Patient Age | Age | |
---|---|---|
Coexisting | Essential | |
Women | 50.99 | 52.82 |
Men | 47.12 | 53.51 |
Total | 48.92 | 53.17 |
ICD-10 Code | Women | Men | Total |
---|---|---|---|
N18 Chronic renal failure | 625 | 627 | 1252 |
U07.1 COVID-19, virus identified | 350 | 515 | 865 |
Z51.1 Chemotherapy session for neoplasm | 322 | 375 | 697 |
Z03.9 Observation for suspected disease or condition, unspecified | 178 | 120 | 298 |
C91.0 Acute lymphoblastic leukemia | 43 | 169 | 212 |
C56 Malignant neoplasm of ovary | 172 | 0 | 172 |
Age Group (Women and Men) | ICD-10 | |
---|---|---|
90+ | I20.0 Unstable angina N30.0 Acute cystitis S72.1 Pertrochanteric fracture | |
80–89 | Z74.3 Need for continuous supervision I74.4 Embolism and thrombosis of arteries of extremities, unspecified I63.8 Other cerebral infarction | |
70–79 | I82.9 Embolism and thrombosis of unspecified vein I84.2 Internal rectal bleeding tumors without complications K57.9 Diverticular disease of the intestine, part unspecified, without perforation or abscess | |
60–69 | C49.4 Connective and soft tissue of the abdomen I10 Essential (primary) hypertension C48.0 Retroperitoneum | |
50–59 | C90 Multiple myeloma and malignant plasma cell neoplasms I11 Hypertensive heart disease C56 Malignant neoplasm of ovary | |
40–49 | R49 Voice disturbances R07 Pain in throat and chest N08.5 Glomerular disorders in systemic connective tissue disorders | |
30–39 | WOMEN 036 Maternal care for other known or suspected fetal problems D64.8 Other specified anemias | MEN D64.8 Other specified anemias |
20–29 | D64.8 Other specified anemias E10.9 Type 1 diabetes mellitus without complications O80.0 Spontaneous vertex delivery | |
10–19 | C81.1 Nodular sclerosis (classical) Hodgkin lymphoma Z94.8 Other transplanted organ and tissue status R76.8 Other specified abnormal immunological findings in serum | |
1–9 | E34.9 Endocrine disorder, unspecified D69.6 Thrombocytopenia, unspecified E30.1 Precocious puberty |
Hospital Ward | Coexisting Diagnosis Average Time of Hospitalization (in Days) | Essential Diagnosis Average Time of Hospitalization (in Days) |
---|---|---|
Department of Adult Psychiatry | 50.96 | |
Department of Anaesthesiology and Intensive Therapy | 0.65 | |
COVID-19 Clinic | 9.42 | 14.19 |
Department of Cardiac Surgery and Vascular Surgery | 3.06 | |
Department of Endocrinology and Internal Medicine | 11.93 | |
II Department of Cardiology | 4.90 | |
Department of Adult Neurology | 12.66 | |
First Department of Cardiology | 8.66 | |
Department of Nephrology, Transplantology, and Internal Diseases | 11.06 | 7.5 |
Clinical Emergency Department | 0.52 | 4.09 |
Department of Oncology and Radiotherapy | 7.32 | |
Department of Hypertension and Diabetology | 3.6 | |
Department of Allergology and Pneumology | 6.85 | |
Department of Hematology and Transplantology | 0.2 | |
Department of Gynecology, Oncological Gynecology, and Gynecological Endocrinology | 3.77 | |
Department of Urology | 0.6 | |
Department of Pediatrics, Hematology, and Oncology | 0.1 | 0.17 |
Department of Pediatric Cardiology and Congenital Heart Defects | 1.17 | |
Department of Otolaryngology with the Department of Maxillofacial Surgery | 0.94 | |
Department of Pediatrics, Diabetology, and Endocrinology | 0.21 | |
Department of Ophthalmology | 0.33 | |
Average | 7.35 | 5.71 |
ICD-10 Code | Women | Men | Total |
---|---|---|---|
F31.6 Bipolar affective disorder, current episode mixed | 82.98 | 82.98 | |
I35.8 Other aortic valve disorders | 39.95 | 39.95 | |
F10.2 Mental and behavioral disorders due to use of alcohol | 18.94 | 18.94 | |
G61.0 Guillain-Barré syndrome | 18.9 | 18.9 | |
I50.0 Congestive heart failure | 15.08 | 15.08 | |
I63.3 Cerebral infarction due to thrombosis of cerebral arteries | 13.25 | 13.25 | |
N18.9 Chronic kidney disease, unspecified | 12.47 | 12.47 | |
C24.9 Biliary tract, unspecified | 11.93 | 11.93 | |
D64.9 Anemia, unspecified | 9.65 | 11.93 | 10.79 |
O99.2 Endocrine, nutritional, and metabolic diseases complicating pregnancy, childbirth, and the puerperium | 10.1 | 10.1 | |
N18.0 Chronic renal failure | 14.7 | 0.3 | 9.9 |
D64.8 Other specified anemias | 9.65 | 9.65 | |
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth, and the puerperium | 9.47 | 9.47 | |
E66.0 Obesity due to excess calories | 9.42 | 9.42 | |
U07.1 COVID-19, virus identified | 4.27 | 12.96 | 8.85 |
O36.7 Maternal care for viable fetus in abdominal pregnancy | 8.83 | 8.83 | |
I63.9 Cerebral infarction, unspecified | 13.25 | 5.83 | 8.30 |
Z51.0 Radiotherapy session | 7.32 | 7.32 | |
M35.9 Systemic involvement of connective tissue, unspecified | 6.97 | 6.97 | |
I50.9 Heart failure, unspecified | 4.52 | 4.52 | |
I47.1 Supraventricular tachycardia | 3.91 | 3.91 | |
O82.1 Delivery by emergency cesarean section | 3.81 | 3.81 | |
I12.0 Hypertensive renal disease with renal failure | 3.69 | 3.69 | |
J15.8 Other bacterial pneumonia | 3.51 | 3.51 | |
I50.1 Left ventricular failure | 3.51 | 3.51 | |
Z03 Medical observation and evaluation for suspected diseases and conditions, ruled out | 3.06 | 3.06 | |
I70.8 Atherosclerosis of other arteries | 3.06 | 3.06 | |
O80.0 Spontaneous vertex delivery | 2.41 | 2.41 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Robakowska, M.; Tyrańska-Fobke, A.; Pogorzelczyk, K.; Synoweć, J.; Ślęzak, D.; Robakowski, P.; Rzońca, P.; Prędkiewicz, P. Patient Management in the Emergency Department during a COVID-19 Pandemic. Healthcare 2022, 10, 1456. https://doi.org/10.3390/healthcare10081456
Robakowska M, Tyrańska-Fobke A, Pogorzelczyk K, Synoweć J, Ślęzak D, Robakowski P, Rzońca P, Prędkiewicz P. Patient Management in the Emergency Department during a COVID-19 Pandemic. Healthcare. 2022; 10(8):1456. https://doi.org/10.3390/healthcare10081456
Chicago/Turabian StyleRobakowska, Marlena, Anna Tyrańska-Fobke, Katarzyna Pogorzelczyk, Joanna Synoweć, Daniel Ślęzak, Piotr Robakowski, Patryk Rzońca, and Paweł Prędkiewicz. 2022. "Patient Management in the Emergency Department during a COVID-19 Pandemic" Healthcare 10, no. 8: 1456. https://doi.org/10.3390/healthcare10081456
APA StyleRobakowska, M., Tyrańska-Fobke, A., Pogorzelczyk, K., Synoweć, J., Ślęzak, D., Robakowski, P., Rzońca, P., & Prędkiewicz, P. (2022). Patient Management in the Emergency Department during a COVID-19 Pandemic. Healthcare, 10(8), 1456. https://doi.org/10.3390/healthcare10081456